CLDX logo

Celldex Therapeutics, Inc. (CLDX)

Profile

Full Name

Celldex Therapeutics, Inc.

Ticker

NASDAQ: CLDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 15, 1986

Indexes

Not included

Website

https://www.celldex.com

Employees

186

Key Details

Price

$25.92(+5.97%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.02M(+1.99% YoY)

Annual EPS

-$2.45(+16.10% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $25.92
    CLDX price is $25.92

    30-Day Relative Volume

    0.92
    CLDX 30-day relative volume is 0.92

    Price Performance

    Price Most recent change

    +5.97%
    CLDX price was up +5.97% on Sep 18, 2025

    Price YTD change

    +2.57%
    CLDX price is up +2.57% since January 1st

    Price 1-year change

    -38.06%
    CLDX price is down -38.06% year-on-year

    Price 3-year change

    -11.38%
    CLDX price is down -11.38% over the past 3 years

    Price Range

    Price All-time high

    $3375.00
    CLDX price is currently -99.23% below its historical high of $3375.00

    Price 3-year low

    $14.40
    CLDX price is currently +80.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.72B
    CLDX market capitalization is $1.72 billion

    Market cap 3-year change

    +25.81%
    CLDX market capitalization is up +25.81% over the past 3 years

    Market cap All-time high

    $3.29B
    CLDX market capitalization is currently -47.61% below its historical high of $3.29 billion

    Market cap sector rank

    78.78%
    CLDX market capitalization is higher than 78.78% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.18%
    CLDX shares outstanding is up +0.18% year-on-year

    Shares Outstanding 3-Year Change

    +41.98%
    CLDX shares outstanding is up +41.98% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.09
    CLDX beta is 1.09

    200-day SMA

    $21.99
    CLDX price is currently +17.86% above its 200-day simple moving average

    50-day SMA

    $23.00
    CLDX price is currently +12.68% above its 50-day simple moving average

    RSI

    64.27
    CLDX 14-day relative strength index is 64.27

    Volume

    0.92
    CLDX 30-day relative volume is 0.92

    ATR

    $1.30
    CLDX average true range is $1.30

    10-day Historical Volatility

    39.58%
    CLDX 10-day historical volatility is 39.58%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.02M
    CLDX annual revenue is $7.02 million

    Revenue Analysts estimate

    $3.57M
    CLDX annual revenue is currently +96.58% higher than the consensus analysts' forecast

    Revenue 1-year change

    +1.99%
    CLDX annual revenue is up +1.99% year-on-year

    Revenue Sector rank

    45.59%
    CLDX annual revenue is higher than 45.59% of companies in Healthcare sector

    EPS

    EPS

    -$2.45
    CLDX annual earnings per share is -$2.45

    EPS Analysts estimate

    -$3.42
    CLDX annual earnings per share is currently -28.33% lower than the consensus analysts' forecast

    EPS 1-year change

    +16.1%
    CLDX annual earnings per share is up +16.1% year-on-year

    EPS Sector rank

    33.67%
    CLDX annual earnings per share is higher than 33.67% of companies in Healthcare sector

    Profit

    Gross profit

    $3.84M
    CLDX annual gross profit is $3.84 million

    Gross margin

    54.74%
    CLDX annual gross profit margin is 54.74%

    Operating profit

    -$195.08M
    CLDX annual operating income is -$195.08 million

    Operating margin

    -2778.89%
    CLDX annual operating profit margin is -2778.89%

    Net income

    -$157.86M
    CLDX annual net profit is -$157.86 million

    Net margin

    -2248.76%
    CLDX annual net profit margin is -2248.76%

    Expenses

    Total expenses

    $202.10M
    CLDX annual total expenses is $202.10 million

    Operating expenses

    $202.10M
    CLDX annual total operating expenses is $202.10 million

    Cost of goods sold

    $3.18M
    CLDX annual cost of goods sold is $3.18 million

    Selling, general & administrative expenses

    $38.55M
    CLDX annual SGA is $38.55 million

    Depreciation and amortization

    $3.18M
    CLDX annual depreciation & amortization is $3.18 million

    Interest expense

    $0.00
    CLDX annual interest expense is $0.00

    Income tax

    $0.00
    CLDX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$195.08M
    CLDX annual earnings before interest & taxes is -$195.08 million

    EBITDA

    -$191.90M
    CLDX annual EBITDA is -$191.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $792.34M
    CLDX annual total assets is $792.34 million

    Non current assets

    $45.18M
    CLDX annual long term assets is $45.18 million

    Current assets

    $747.16M
    CLDX annual total current assets is $747.16 million

    Cash and cash equivalents

    $28.36M
    CLDX annual cash & cash equivalents is $28.36 million

    Accounts receivable

    $700.00K
    CLDX annual accounts receivable is $700.00 thousand

    Inventory

    $0.00
    CLDX annual inventory is $0.00

    Liabilities

    Total liabilities

    $45.34M
    CLDX annual total liabilities is $45.34 million

    Long term liabilities

    $5.83M
    CLDX annual total long term liabilities is $5.83 million

    Current liabilities

    $39.50M
    CLDX annual total current liabilities is $39.50 million

    Accounts payable

    $3.27M
    CLDX annual accounts payable is $3.27 million

    Debt

    Total debt

    $3.81M
    CLDX annual total debt is $3.81 million

    Total debt 1-year change

    +50%
    CLDX annual total debt is up +50% year-on-year

    Long term debt

    $2.36M
    CLDX annual long term debt is $2.36 million

    Short term debt

    $1.45M
    CLDX annual short term debt is $1.45 million

    Equity & Capital

    Shareholders equity

    $747.00M
    CLDX annual stockholders equity is $747.00 million

    Book value

    $747.00M
    CLDX annual book value is $747.00 million

    Retained earnings

    -$1.56B
    CLDX annual retained earnings is -$1.56 billion

    Working capital

    $707.66M
    CLDX annual working capital is $707.66 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$157.78M
    CLDX annual cash flow from operations is -$157.78 million

    Cash from operations 1-year change

    -47.06%
    CLDX annual cash flow from operations is down -47.06% year-on-year

    Cash from investing

    -$290.13M
    CLDX annual cash flow from investing activities is -$290.13 million

    Cash from investing 1-year change

    -174.27%
    CLDX annual cash flow from investing activities is down -174.27% year-on-year

    Cash from financing

    $441.45M
    CLDX annual cash flow from financing activities is $441.45 million

    Cash from financing 1-year change

    +102.07%
    CLDX annual cash flow from financing activities is up +102.07% year-on-year

    CAPEX

    CAPEX

    $1.92M
    CLDX annual capital expenditures is $1.92 million

    CAPEX 1-year change

    +5.56%
    CLDX annual capital expenditures is up +5.56% year-on-year

    Free Cash Flow

    Free cash flow

    -$159.70M
    CLDX annual free cash flow is -$159.70 million

    Free cash flow 1-year change

    -46.36%
    CLDX annual free cash flow is down -46.36% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    54.74%
    CLDX annual gross profit margin is 54.74%

    Operating margin

    -2778.89%
    CLDX annual operating profit margin is -2778.89%

    Net margin

    -2248.76%
    CLDX annual net profit margin is -2248.76%

    ROA & ROE

    ROA

    -25.10%
    CLDX annual return on assets is -25.10%

    ROE

    -26.84%
    CLDX annual return on equity is -26.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CLDX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CLDX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.63
    CLDX price to book ratio is 2.63

    PB ratio Sector rank

    60.64%
    CLDX price to book ratio is higher than 60.64% of companies in Healthcare sector

    PS Ratio

    PS ratio

    297.23
    CLDX price to sales ratio is 297.23

    PS ratio Sector rank

    94.18%
    CLDX price to sales ratio is higher than 94.18% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.10B
    CLDX enterprise value is $1.10 billion

    Enterprise value Sector rank

    74.11%
    CLDX enterprise value is higher than 74.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.75
    CLDX EV/EBITDA is -4.75

    EV/EBITDA Sector rank

    24.13%
    CLDX EV/EBITDA is higher than 24.13% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    18.91
    CLDX annual current ratio is 18.91

    Quick ratio

    18.91
    CLDX annual quick ratio is 18.91

    Leverage

    Debt to equity

    0.00
    CLDX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CLDX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    1
    CLDX piotroski f-score is 1

    Altman Z-Score

    20.30
    CLDX altman z-score is 20.30

    Analyst ratings

    Recent major analysts updates

    Aug 20, 25 Wells Fargo
    Overweight
    Aug 20, 25 HC Wainwright & Co.
    Buy
    Aug 20, 25 Citigroup
    Buy
    Aug 20, 25 Canaccord Genuity
    Buy
    Jun 16, 25 HC Wainwright & Co.
    Buy
    Jun 13, 25 HC Wainwright & Co.
    Buy
    May 9, 25 UBS
    Buy
    May 9, 25 Morgan Stanley
    Overweight
    May 9, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Goldman Sachs
    Neutral

    Institutional Ownership

    Screeners with CLDX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Celldex Therapeutics, Inc.?
    • Does Celldex Therapeutics, Inc. pay dividends?
    • What sector is Celldex Therapeutics, Inc. in?
    • What industry is Celldex Therapeutics, Inc. in?
    • What country is Celldex Therapeutics, Inc. based in?
    • When did Celldex Therapeutics, Inc. go public?
    • Is Celldex Therapeutics, Inc. in the S&P 500?
    • Is Celldex Therapeutics, Inc. in the NASDAQ 100?
    • Is Celldex Therapeutics, Inc. in the Dow Jones?
    • When was Celldex Therapeutics, Inc.'s last earnings report?
    • When does Celldex Therapeutics, Inc. report earnings?

    What is the ticker symbol for Celldex Therapeutics, Inc.?

    The ticker symbol for Celldex Therapeutics, Inc. is NASDAQ:CLDX

    Does Celldex Therapeutics, Inc. pay dividends?

    No, Celldex Therapeutics, Inc. does not pay dividends

    What sector is Celldex Therapeutics, Inc. in?

    Celldex Therapeutics, Inc. is in the Healthcare sector

    What industry is Celldex Therapeutics, Inc. in?

    Celldex Therapeutics, Inc. is in the Biotechnology industry

    What country is Celldex Therapeutics, Inc. based in?

    Celldex Therapeutics, Inc. is headquartered in United States

    When did Celldex Therapeutics, Inc. go public?

    Celldex Therapeutics, Inc.'s initial public offering (IPO) was on May 15, 1986

    Is Celldex Therapeutics, Inc. in the S&P 500?

    No, Celldex Therapeutics, Inc. is not included in the S&P 500 index

    Is Celldex Therapeutics, Inc. in the NASDAQ 100?

    No, Celldex Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Celldex Therapeutics, Inc. in the Dow Jones?

    No, Celldex Therapeutics, Inc. is not included in the Dow Jones index

    When was Celldex Therapeutics, Inc.'s last earnings report?

    Celldex Therapeutics, Inc.'s most recent earnings report was on May 12, 2025

    When does Celldex Therapeutics, Inc. report earnings?

    The next expected earnings date for Celldex Therapeutics, Inc. is November 5, 2025
    On this page